Seminars in Oncology Nursing
Volume 22, Issue 2 , Pages 80-89 , May 2006

AIDS-Related Lymphoma

  • Alexandra M. Levine

      Affiliations

    • Corresponding Author InformationAddress correspondence to Alexandra M. Levine, MD, USC/Norris Cancer Hospital, 1441 Eastlake Ave, Room 3468, Los Angeles, CA 90033;

References 

  1. Frizzera C , Rosai J , Dehner LP , et al.   Lymphoreticular disorders in primary immunodeficiency (New findings based on an updated histologic classification of 35 cases) . Cancer . 1980;46:692–699
  2. Penn I . Tumors of the immunocompromised patient . Annu Rev Med . 1988;39:63–73
  3. Purtilo DT . Opportunistic non-Hodgkin’s lymphoma in X-linked recessive immunodeficiency and lymphoproliferative syndromes . Semin Oncol . 1977;4:335–343
  4. Zulman J , Jaffe R , Talal N . Evidence that the malignant lymphoma of Sjogren’s syndrome is a monoclonal D cell neoplasm . N Engl J Med . 1978;299:1215–1220
  5. Anderson LG , Talal N . The spectrum of benign to malignant lymphoproliferation in Sjogren’s syndrome . Clin Exp Immunol . 1972;10:199–201
  6. Burke JS , Butler J , Fuller LM . Malignant lymphomas of the thyroid (A clinical-pathologic study of 35 patients including ultrastructural observations) . Cancer . 1977;39:1587–1602
  7. Levine AM , Taylor CR , Schneider DR , et al.   Immunoblastic sarcoma of T cell versus B cell origin: I. Clinical features . Blood . 1981;58:52–61
  8. Penn I . Cancers complicating organ transplantation . N Engl J Med . 1990;323:1767–1769
  9. Swinnen LJ , Costanzo-Nordin MR , Fisher SG , et al.   Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients . N Engl J Med . 1990;323:1723–1728
  10. Centers for Disease Control . Diffuse, undifferentiated non-Hodgkin’s lymphoma among homosexual males—United States . MMWR Morb Mortal Wkly Rep . 1982;31:277–279
  11. Centers for Disease Control. Update on acquired immune deficiency syndrome (AIDS)—United States . MMWR Morb Mortal Wkly Rep . 1982;31:507–508
  12. Centers for Disease Control. Revision of the case definition of acquired immunodeficiency syndrome for national reporting—United States . Ann Intern Med . 1985;103:373–375
  13. Beral V , Peterman T , Berkelman R , et al.   AIDS-associated non-Hodgkin’s lymphoma . Lancet . 1991;337:805–809
  14. Palella FJ , Delaney KM , Moorman AC , et al.   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection . N Engl J Med . 1998;338:853–860
  15. Ledergerber B , Telenti A , Effer M . Risk of HIV related Kaposi’s sarcoma and non-Hodgkin’s lymphoma with potent antiretroviral therapy (Prospective cohort study) . Br Med J . 1999;319:23–24
  16. Mocroft A , Katama C , Johnson AM , et al.   AIDS across Europe, 1994-1998 (The EuroSIDA study) . Lancet . 2000;356:291–296
  17. Levine AM . Lymphoma complicating immunodeficiency disorders . Ann Oncol . 1994;4(suppl 2):S29–S35
  18. DeVesa SS , Fears T . Non-Hodgkin’s lymphoma time trends: U.S. and international data . Cancer Res . 1992;52:5432–5440
  19. Rabkin CS , Biggar RJ , Horm JW . Increasing incidence of cancers associated with the human immunodeficiency virus epidemic . Int J Cancer . 1991;47:692–696
  20. Biggar RJ , Rabkin CS . The epidemiology of acquired immunodeficiency syndrome-related lymphomas . Curr Opin Oncol . 1992;4:883–893
  21. Grulich AE , Wan X , Law MG , et al.   B cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin’s lymphoma in people with AIDS . AIDS . 2000;14: 144-140
  22. Cote TR , Biggar RF , Rosenberg PS , et al.   Non-Hodgkin’s lymphoma among people with AIDS (Incidence, presentation and public health burden) . Int J Cancer . 1997;73:645–650
  23. Biggar RJ , Rosenberg PS , Cote T . Kaposi’s sarcoma and non-Hodgkin’s lymphoma following the diagnosis of AIDS . Int J Cancer . 1996;68:754–758
  24. Biggar RJ , Engels EA , Frisch M , et al.   Risk of T cell lymphomas in persons with AIDS . J AIDS . 2001;26:371–376
  25. Peters BS , Beck E , Coleman DG , et al.   Changing disease patterns in patients with AIDS in a referral center in the United Kingdom (The changing face of AIDS) . Br Med J . 1991;302:203–207
  26. Nelson RA , Levine AM , Bernstein L . Reproductive factors and risk of intermediate or high grade B cell non-Hodgkin’s lymphoma in women . J Clin Oncol . 2001;19:1381–1387
  27. Holly EA , Lele C , Bracci P . Non-Hodgkin’s lymphoma in homosexual men in the San Francisco Bay area (Occupational, chemical and environmental exposures) . J AIDS . 1997;15:223–231
  28. Dean M , Jacobson LP , McFarlane G , et al.   Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-Δ32 mutation . Cancer Res . 1999;59:3561–3564
  29. Rabkin CS , Yang Q , Goedert JJ , et al.   Chemokine and chemokine receptor gene variants and risk of non-Hodgkin’s lymphoma in human immunodeficiency virus-1 infected individuals . Blood . 1999;93:1838–1842
  30. Besson C , Goubar A , Gabarre J , et al.   Changes in AIDS related lymphoma since the era of highly active antiretroviral therapy . Blood . 2001;98:2339–2344
  31. NCI Non-Hodgkin’s Lymphoma Classification Project Writing Committee . Classification of Non-Hodgkin’s lymphomas (Reproducibility of major classification systems) . Cancer . 1985;55:91–95
  32. Levine AM , Gill PS , Meyer PR , et al.   Retrovirus and malignant lymphoma in homosexual men . JAMA . 1985;254:1921–1925
  33. Knowles DM , Chamulak GA , Subar M , et al.   Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS) (The New York University experience) . Ann Intern Med . 1988;108:744–753
  34. Lowenthal DA , Straus DJ , Campbell SW , et al.   AIDS-related lymphoid neoplasia (The Memorial Hospital experience) . Cancer . 1988;61:2325–2337
  35. Kaplan LD , Abrams DI , Feigal E , et al.   AIDS-associated non-Hodgkin’s lymphoma in San Francisco . JAMA . 1989;261:719–724
  36. Ziegler JL , Beckstead JA , Volberding PA , et al.   Non-Hodgkin’s lymphoma in 90 homosexual men (Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome) . N Engl J Med . 1984;311:565–570
  37. Lukes RJ , Parker JW , Taylor CR , et al.   Immunologic approach to non-Hodgkin’s lymphomas and related leukemias (Analysis of the results of multiparameter studies of 425 cases) . Semin Hematol . 1978;15:322–351
  38. Centers for Disease Control. Revision of the Centers for Disease Control and Prevention surveillance case definition for acquired immunodeficiency syndrome . MMWR Morb Mortal Wkly Rep . 1987;36(suppl 1):lS–15S
  39. Levine AM . Acquired immunodeficiency syndrome-related lymphoma [Review] . Blood . 1992;80:8–20
  40. Levine AM , Sadeghi S , Espina B , et al.   characteristics of indolent non-Hodgkin’s lymphoma in patients with type 1 Human Immunodeficiency virus infection . Cancer . 2002;94:1500–1506
  41. Horning SJ , Rosenberg SA . The natural history of initially untreated low-grade non-Hodgkin’s lymphomas . N Engl J Med . 1984;311:1471–1475
  42. Ciobanu N , Andreef M , Safai B , et al.   Lymphoblastic neoplasia in a homosexual patient with Kaposi’s sarcoma . Ann Intern Med . 1983;98:151–155
  43. Presant CA , Gala K , Wiseman C , et al.   Human immunodeficiency virus-associated T-cell lymphoblastic lymphoma in AIDS . Cancer . 1987;60:1459–1461
  44. Goldstein J , Becker N , DelRowe J , et al.   Cutaneous T-cell lymphoma in a patient infected with HIV, type 1 . Cancer . 1990;66:1130–1132
  45. Crane GA , Variakojis D , Rosen ST , et al.   Cutaneous T-cell lymphoma in patients with human immunodeficiency virus infection . Arch Dermatol . 1991;127:989–994
  46. Sternlieb J , Mintzer D , Kwa D , et al.   Peripheral T-cell lymphoma in a patient with the acquired immunodeficiency syndrome . Am J Med . 1988;85:445
  47. Shibata D , Brynes R , Rabinowitz A , et al.   HTLV-I associated adult T cell leukemia lymphoma in a patient infected with HIV-1 . Ann Intern Med . 1989;111:871–875
  48. Gill PS , Harrington W , Kaplan MH , et al.   Treatment of adult T cell leukemia-lymphoma with a combination of interferon alpha and zidovudine . N Engl J Med . 1995;332:1744–1748
  49. Chadburn A , Cesarman E , Jagirdar J , et al.   CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the HIV . Cancer . 1993;72:3078–3090
  50. Seneviratne L , Tulpule A , Espina BM , et al.   Clinical, immunologic and pathologic correlates of bone marrow involvement in 291 patients with AIDS related lymphoma . Blood . 2001;98:2358–2363
  51. Levine AM , Zuckerman E , Zuckerman T , et al.   Lack of association between hepatitis C infection and development of AIDS related lymphoma . J AIDS Hum Retrovirol . 1999;20:255–258
  52. Zuckerman E , Zuckerman T , Douer D , et al.   Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies . Cancer . 1998;83:1224–1230
  53. Straus DJ , Juang J , Testa MA , et al.   Prognostic factors in the treatment of HIV associated non-Hodgkin’s lymphoma: Analysis of AIDS Clinical Trials Group protocol 142: Low dose versus standard dose m-BACOD plus GM-CSF . J Clin Oncol . 1998;16:3601–3606
  54. Lim ST , Karim R , Nathwani BN , et al.   AIDS related Burkitt’s lymphoma versus diffuse large cell lymphoma in the pre-HAART and HAART eras (Significant differences in survival with standard chemotherapy) . J Clin Oncol . 2005;23:4430–4438
  55. Rossi G , Donisi A , Casari S , et al.   The International Prognostic Index can be used as a guide to treatment decisions regarding patients with HIV related systemic non-Hodgkin’s lymphoma . Cancer . 1999;86:2391–2397
  56. Lim ST , Karim R , Tulpule A , et al.   Prognostic factors in HIV related diffuse large cell lymphoma (Before versus after highly active antiretroviral therapy) . J Clin Oncol . 2005;23:8477–8482
  57. Levine AM , Wernz JC , Kaplan L , et al.   Low dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma (A prospective multi-institutional trial) . JAMA . 1991;266:84–88
  58. Kaplan LD , Straus DJ , Testa MA , et al.   Randomized trial of standard-dose versus low dose mBACOD chemotherapy for HIV-associated non-Hodgkin’s lymphoma . N Engl J Med . 1997;336:1641–1648
  59. Ratner L , Lee J , Tang S , et al.   Chemotherapy for HIV associated non-Hodgkin’s lymphoma in combination with highly active anti-retroviral therapy . J Clin Oncol . 2001;19:2171–2178
  60. Gill PS , Rarick MU , Brynes RL , et al.   Azidothymidine and bone marrow failure in AIDS . Ann Intern Med . 1987;107:502–505
  61. Antinori A , Cingolani A , Alba L , et al.   Better response to chemotherapy and prolonged survival in AIDS related lymphomas responding to highly active antiretroviral therapy . AIDS . 2001;15:1483–1491
  62. Vaccher E , Spina M , de Gennaro G , et al.   concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with Human Immunodeficiency Virus-related non-Hodgkin’s lymphoma . Cancer . 2001;91:155–163
  63. Hoffmann C , Wolf E , Fatkenheuer G , et al.   Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS related lymphoma . AIDS . 2003;17:1521–1529
  64. Little RF , Pittaluga S , Grant N , et al.   Highly effective treatment of acquired immunodeficiency syndrome related lymphoma with dose adjusted EPOCH (Impact of antiretroviral therapy suspension and tumor biology) . Blood . 2003;101:4653–4659
  65. Coiffier B , Lepage E , Briere J , et al.   CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B cell lymphoma . N Engl J Med . 2002;346:235–242
  66. Kaplan LD , Scadden DT . No benefit from rituximab in a randomized phase III trial of CHOP with or without rituximab for patients with HIV associated non-Hodgkin’s lymphoma (AIDS malignancies consortium study 010 [abstract 2268]) . Proc Am Soc Clin Oncol . 2003;22:564
  67. Meynard J-L , Guiguet M , Fonquernie L , et al.   Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV infected patients and their epidemiologic characteristics . HIV Med . 2003;4:127–132
  68. Borg C , Ray-Coquard I , Philip I , et al.   CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer . Cancer . 2004;101:2675–2680
  69. Boue F , Gabarre J , Gisselbrecht C , et al.   CHOP chemotherapy plus rituximab in HIV patients with high grade lymphoma-results of an ANRS trial [abstract 1824] . Blood . 2002;100:470a
  70. Errante D , Santarossa S , Antinori A , et al.   Second line chemotherapy with CDE in patients with resistant HIV related non-Hodgkin’s lymphoma [abstract] . Proc Am Soc Clin Oncol . 1998;17:57a
  71. Bi J , Espina BM , Tulpule A , et al.   High dose cytosine arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS related non-Hodgkin’s lymphoma . J AIDS . 2001;28:416–421
  72. Krishnan A , Zaia J , Forman SJ . Should HIV positive patients with lymphoma be offered stem cell transplants? . Bone Marrow Transplant . 2003;32:741–748

PII: S0749-2081(06)00013-1

doi: 10.1016/j.soncn.2006.01.004

Seminars in Oncology Nursing
Volume 22, Issue 2 , Pages 80-89 , May 2006

Article Tools